Prenosis
About:
An AI company enabling precision medicine for infection. The world leader in data and insights for abnormal immune response in acute care.
Website: http://www.prenosis.com
Twitter/X: prenosisinc
Top Investors: National Science Foundation, PACE Healthcare Capital, National Institute of General Medical Science, Defense Threat Reduction Agency (DTRA)
Description:
Prenosis, Inc. is an artificial intelligence company enabling precision medicine in acute care. At Prenosis we believe healthcare should be tailored to individual biology. With our data-driven approach to fast-moving biology in acute care environments, we're ushering in a new era of precision medicine in acute care. Our Immunix™ precision medicine platform generates proprietary biological insights to rapidly develop precision medicine products and enables the real-time delivery of optimal precision therapy in acute care. The platform is based on the world's largest and fastest-growing biomarker-clinical dataset for rapid immune response. Using Immunix™, we created and validated the Sepsis ImmunoScore™, the first FDA-authorized AI diagnostic for sepsis. At Prenosis, we enable the healthcare ecosystem to see people differently. More information at: www.prenosis.com
$11.5M
$1M to $10M
Chicago, Illinois, United States
2014-01-01
bobby.reddy.jr(AT)prenosis.com
Bobby Reddy, Jr., Rashid Bashir
11-50
2023-07-12
Private
© 2024 MyAiNote.com